coya therapeutics coya opened up its shares for public trading for the first time since it filed for ipo in november 2022 the company agreed to initially offer 305 million shares to the public at 500 per share on its first day of trading the stock decreased 379 from its opening price of 475 to its closing price of 457 coya therapeutics performance on first day of trading about coya therapeutics and its ipo coya therapeutics inc is a clinicalstage biotechnology company developing proprietary treatments focused on the biology and potential therapeutic advantages of regulatory t cells tregs to target systemic inflammation and neuroinflammation for its ipo coya agreed to offer 305 million shares at a price of 500 per share with an insider lockup period of 180 days ending on june 27 2023 an insider lockup period is a period of time after a company first goes public where major shareholders are not allowed to sell their shares the insider lockup period makes sure that the market does not get oversupplied with shares of the company traders may short the stock leading up to the lockupperiod expiration date in hopes that the price will fall due to an increase in supply of shares retail traders should be watching this stocks short interest as it moves closer to lockup expiration see also benzingas most shorted stocks this article was generated by benzingas automated content engine and reviewed by an editor